These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31960208)

  • 1. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
    Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
    Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease.
    Hsieh CW; Chen YM; Lin CC; Tang KT; Chen HH; Hung WT; Lai KL; Chen DY
    J Rheumatol; 2017 Aug; 44(8):1142-1150. PubMed ID: 28507179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
    Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
    Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
    J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
    Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
    Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
    Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
    Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
    Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
    Front Immunol; 2021; 12():719544. PubMed ID: 34367188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
    Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
    Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
    Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
    Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
    Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
    J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mCRP as a Biomarker of Adult-Onset Still's Disease: Quantification of mCRP by ELISA.
    Fujita C; Sakurai Y; Yasuda Y; Homma R; Huang CL; Fujita M
    Front Immunol; 2022; 13():938173. PubMed ID: 35844576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult‑onset Still's disease.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Gung NR; Hung WT; Tzang BS; Hsu TC
    Mol Med Rep; 2018 Feb; 17(2):3364-3371. PubMed ID: 29257322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional association of interleukin 18 gene -607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
    J Rheumatol; 2009 Oct; 36(10):2284-9. PubMed ID: 19684151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
    Fujita Y; Yago T; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Yashiro-Furuya M; Suzuki E; Watanabe H; Kawakami A; Migita K
    PLoS One; 2021; 16(8):e0255493. PubMed ID: 34351954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.